Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S has announced an ambitious share repurchase program, with plans to buy back B shares worth up to DKK 20 billion over 12 months starting February 2024. As a part of this program, they have initiated a repurchase of shares up to DKK 2.2 billion from May to August 2024. The company’s commitment to defeating serious chronic diseases is backed by a strong heritage in diabetes care and a global presence, employing 66,000 people worldwide.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
